Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-20

Clinical Trial Update: Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating efficacy and safety of a probiotic formulation in adults with irritable bowel syndrome with diarrhea (IBS-D).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic formulation (unspecified) (probiotic)

Snippet

Sponsor: Lallemand Health Solutions | Conditions: IBS - Irritable Bowel Syndrome | Phase 4 | Status: UNKNOWN